Investment Rating - The report maintains a "Buy" rating for Li Ning (2331.HK) [1] Core Views - Li Ning's 2025 annual performance exceeded expectations, with revenue of 29.6 billion RMB, a year-on-year increase of 3.2%, and a net profit of 2.94 billion RMB, a decrease of 2.6% [5][10] - The company plans to increase its investment in Olympic-related initiatives and outdoor product lines to drive future growth [10][11] - The company has adjusted its earnings forecasts for 2026-2028, expecting net profits of 2.91 billion, 3.34 billion, and 3.67 billion RMB respectively, with corresponding EPS of 1.13, 1.29, and 1.42 RMB [11] Financial Performance - In 2025, the gross margin decreased by 0.4 percentage points to 49%, while the operating profit margin increased by 0.4 percentage points to 13.2% [8][9] - Revenue contributions by product category in 2025 were 49.5% from footwear, 41.6% from apparel, and 8.9% from equipment and accessories, with respective year-on-year growth of 2.4%, 2.3%, and 12.7% [6] - The company’s total sales points reached 7,609, with a net increase of 24 points from the beginning of the year [7] Operational Insights - The company’s average monthly sales per store for the Li Ning brand was 284,000 RMB, with a penetration rate of 30% for its ninth-generation stores [7] - The retail sales of the Li Ning brand remained flat year-on-year, with notable growth in running and training categories, while basketball and sports leisure categories saw declines [7][10] - The company has introduced new store formats and product lines in anticipation of the Olympic Games, aiming to enhance brand visibility and sales [10] Future Outlook - The company expects high single-digit revenue growth in 2026, driven by Olympic sponsorship and new product launches [10][11] - The report indicates that while revenue growth is anticipated, profit margins may face pressure due to increased marketing expenditures [10]

Investment Rating - The report maintains a "Buy" rating for the engineering machinery industry [1] Core Insights - In January-February 2026, excavator sales in China (including exports) reached 35,934 units, a year-on-year increase of 13.1%, while domestic sales were 15,478 units, down 9.2% due to the impact of the Spring Festival [3] - The report highlights a significant recovery in the demand for non-excavator machinery, with loader sales increasing by 11.5% and crawler crane sales rising by 30.3% year-on-year [3] - The government plans to allocate 755 billion yuan for central budget investments and 800 billion yuan for long-term special bonds to support infrastructure construction, which is expected to drive the recovery of the engineering machinery sector [4] - Excavator exports surged to 20,456 units, a 38.8% increase year-on-year, indicating strong international demand [5] - Electric loader sales saw a remarkable growth of 112.7%, with an electrification rate of 24.1%, reflecting a shift towards green and low-carbon technologies in the industry [6] - Forklift sales increased by 14.1%, with a notable rise in the demand for unmanned forklifts driven by advancements in robotics and artificial intelligence [7] - The mining machinery sector is experiencing sustained growth, with global market size projected to increase from 123 billion USD in 2025 to 160 billion USD by 2030, indicating significant opportunities for domestic manufacturers [9] - The commencement of the Yarlung Tsangpo River hydropower project, with an estimated investment of 1.2 trillion yuan, is expected to further boost demand for engineering machinery [10] Summary by Sections Excavator Sales - In January-February 2026, excavator sales were 35,934 units, with domestic sales down 9.2% and exports up 38.8% [3][5] Loader and Crane Sales - Loader sales increased by 11.5%, and crawler crane sales rose by 30.3% year-on-year [3] Government Support - The government is set to invest 755 billion yuan in infrastructure, which will support the engineering machinery sector [4] Electric Machinery - Electric loader sales reached 5,132 units, a 112.7% increase, with an electrification rate of 24.1% [6] Forklift Market - Forklift sales grew by 14.1%, with a significant rise in unmanned forklift adoption [7] Mining Machinery - The global mining machinery market is expected to grow significantly, providing opportunities for domestic companies [9] Major Projects - The Yarlung Tsangpo River hydropower project is anticipated to drive demand for engineering machinery [10]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The company reported a revenue of 2.45 billion yuan in 2025, a year-on-year decrease of 18.9%, and a net profit attributable to shareholders of 1.29 billion yuan, down 34.1% year-on-year [5] - The decline in performance is attributed to weak demand and increased competition, although the revenue drop in Q4 2025 has narrowed [6] - The company has made significant progress in the regenerative and botulinum toxin sectors, enhancing its product portfolio and market position [9] - Despite short-term challenges, the company has a robust pipeline of new products and is expected to benefit from the introduction of new offerings [10] Financial Performance Summary - In 2025, the company's revenue by product category was 1.26 billion yuan for solution products and 0.89 billion yuan for gel products, with respective year-on-year declines of 27.5% and 26.8% [6] - The gross margin decreased by 1.9 percentage points to 92.7%, while the net profit margin fell by 12.1 percentage points to 52.6% [7] - The company’s operating expenses increased by 16.0 percentage points to 38.2% in 2025, driven by higher sales and management costs [8] Product Development and Market Position - The company has diversified its product offerings, successfully acquiring REGEN Biotech, Inc. and launching new products in the regenerative and botulinum toxin categories [9] - The approval of the botulinum toxin product Hutox® is expected to contribute significantly to revenue, with potential annual sales of up to 600 million yuan [9] - The company’s strategy to enhance its product mix and leverage existing distribution channels is anticipated to strengthen its competitive edge [10] Earnings Forecast - The report projects a slight decrease in net profit forecasts for 2026 and 2027 to 1.45 billion yuan and 1.68 billion yuan, respectively, with an introduction of a new forecast for 2028 at 2.13 billion yuan [10] - The expected earnings per share (EPS) for 2026, 2027, and 2028 are 4.78 yuan, 5.56 yuan, and 7.04 yuan, respectively [10]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Insights - The skincare business is expected to regain momentum in the second half of the year, while the medical aesthetics segment is building a new growth curve [1] - The company reported a revenue of 5.52 billion yuan for 2025, a slight decrease of 0.4% year-on-year, and a net profit attributable to shareholders of 1.91 billion yuan, down 7.2% year-on-year [3][4] - The first half of 2025 saw a revenue of 3.11 billion yuan, up 22.5% year-on-year, while the second half experienced a decline of 19.8% [3][4] Revenue Performance - The company's professional skincare products generated revenue of 5.50 billion yuan in 2025, with functional skincare products accounting for 4.34 billion yuan, a year-on-year increase of 0.8% [4] - The revenue from the medical dressing segment was 1.16 billion yuan, down 4.8% year-on-year [4] - The company's main brand, 可复美, generated 4.47 billion yuan in revenue, a decrease of 1.6% year-on-year, while the 可丽金 brand saw a revenue increase of 9.2% to 0.92 billion yuan [4] Product and Brand Development - In 2025, the company launched the 可复美胶原棒 2.0 and plans to introduce significant new products in 2026 [5] - The company is also focusing on expanding its product matrix with new launches in various series, which is expected to optimize revenue structure [7] Financial Metrics - The company's gross margin decreased by 1.8 percentage points to 80.3% in 2025, attributed to changes in product mix and a decline in high-margin medical dressing revenue [6] - The sales, management, and R&D expense ratios were 37.3%, 3.1%, and 1.6% respectively, with an increase in sales expense ratio due to heightened brand investment [6] Future Outlook - The company is expected to return to a growth trajectory through continuous product innovation and expansion in the medical aesthetics sector [7] - The net profit forecasts for 2026 and 2027 have been adjusted to 2.01 billion yuan and 2.37 billion yuan, respectively, reflecting a downward revision of 42% and 47% [7]

Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of Fuyao Glass, with target prices set at RMB 74.85 and HKD 75.60 respectively [4][6]. Core Insights - Fuyao Glass reported a total revenue of RMB 45.79 billion for 2025, a year-on-year increase of 16.7%, and a net profit attributable to shareholders of RMB 9.31 billion, up 24.2% year-on-year. However, the Q4 2025 performance was below expectations due to challenges in new capacity release and lower-than-expected demand in both domestic and U.S. markets [1][2]. - The company experienced a robust gross margin of 37.3% in 2025, with a slight increase of 1.0 percentage points year-on-year. The gross margin for Q4 2025 was 37.0%, reflecting a year-on-year increase of 4.9 percentage points [2][3]. - Fuyao Glass's capital expenditure for 2025 was RMB 6.16 billion, primarily for new factories in Anhui and Fuzhou, and the second phase of the U.S. factory. The management has guided a capital expenditure of RMB 7.73 billion for 2026, focusing on existing projects without new business investments [3]. Summary by Relevant Sections Financial Performance - In 2025, automotive glass sales volume increased by 8.5%, with an average selling price (ASP) growth of 8.1%, leading to automotive glass revenue of RMB 41.89 billion, a 17.3% increase year-on-year. Domestic and overseas automotive glass revenues grew by 14.5% and 20.9% respectively [2]. - The report forecasts a net profit of approximately RMB 10.84 billion for 2026, reflecting a growth rate of 16.43% [5]. Market Position and Strategy - Fuyao Glass is enhancing its product mix with high-value-added products, achieving a global market share increase in automotive glass. The company is also expanding its aluminum trim business, with production bases in Fuzhou and Changchun already operational [3]. - The company has maintained a high dividend payout ratio, with a projected dividend payout of about 59% for 2025, indicating strong shareholder returns [3]. Valuation Metrics - The report provides a valuation summary indicating a P/E ratio of 20 for 2024, decreasing to 10 by 2028, reflecting a positive outlook on earnings growth [5][14]. - The estimated EPS for 2026 is RMB 4.15, with a projected ROE of 23.95% [5][13].

Revenue Performance - In January-February 2026, the national general public budget revenue increased by 0.7% year-on-year, improving from a decline of 1.7% in the previous period[1] - The central government budget revenue decreased by 1.7%, but the decline was significantly narrowed compared to the previous month[3] - Local government budget revenue grew by 2.6%, maintaining positive growth despite a slowdown[3] Tax Revenue Insights - The four major tax categories showed mixed results, with individual income tax declining by 6.9% year-on-year, a significant drop from a previous increase of 11.38%[4] - Domestic value-added tax increased by 4.7%, reversing a three-month decline and improving by 6.85 percentage points from the previous month[5] - Corporate income tax saw a reduced decline of 3.9%, improving by 14.42 percentage points compared to the previous month[5] Expenditure Trends - General public budget expenditure grew by 3.6% year-on-year, a significant increase of 5.37 percentage points from the previous month[12] - Infrastructure-related expenditure increased by 2.41%, marking a positive turnaround with a rise of 3.51 percentage points from the previous month[12] - Government fund budget expenditure rose by 16.0%, a substantial increase of 14.5 percentage points from the previous month[24] Special Debt Issuance - New local special bond issuance reached 824.2 billion yuan in January-February 2026, with an issuance progress of 18.7%, surpassing the five-year average of 14%[31] - By March 19, 2026, the cumulative issuance of new local special bonds reached 1,091.4 billion yuan, completing 24.8% of the annual plan[31] Overall Economic Outlook - The fiscal situation at the beginning of 2026 appears positive, with rising main tax revenues and rapid special bond issuance supporting revenue growth[2] - The acceleration of fiscal expenditure is expected to provide fundamental support for maintaining positive momentum in infrastructure investment[2]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected investment return exceeding the market benchmark by more than 15% over the next 6-12 months [4]. Core Insights - The company achieved a revenue of 3.758 billion RMB in 2025, representing a year-on-year growth of 57.7%, surpassing Bloomberg's consensus estimate of 3.590 billion RMB [1]. - The revenue growth was primarily driven by strong demand for the J6 chip and rapid growth in high-end solutions, which contributed to an increase in average selling price (ASP) [1]. - The gross margin for 2025 was reported at 64.5%, a decline of 12.8 percentage points year-on-year, attributed to a higher proportion of automotive product solutions, which have lower margins compared to licensing and service revenues [1]. - Research and development (R&D) expenses significantly increased to 5.154 billion RMB, a 63.3% rise year-on-year, leading to an adjusted operating loss of 2.372 billion RMB [1]. Revenue Breakdown - The company's product solutions generated revenue of 1.622 billion RMB in 2025, a substantial increase of 144.2% year-on-year, with the revenue contribution rising from 27.9% in 2024 to 43.2% in 2025 [2]. - The delivery volume of product solutions exceeded 4 million units, with mid-to-high-end products accounting for 45% of total deliveries, marking a 4.8-fold increase from 2024 [2]. - The company holds a leading market share in the basic auxiliary driving solutions for self-owned brand car manufacturers, with a 47.7% share in the mid-to-high-end intelligent driving market [2]. Profitability and Forecast - The licensing and service business revenue grew to 1.935 billion RMB, a 17.4% increase year-on-year, with a gross margin of 94.5%, up 2.5 percentage points [3]. - The report projects revenue for 2026 and 2027 to be 5.905 billion RMB and 9.097 billion RMB, respectively, reflecting an upward revision of 10% and 15% from previous estimates [4]. - The net profit forecast for 2028 is expected to reach 1.278 billion RMB, with a corresponding price-to-sales (P/S) ratio of 7x based on the stock price of 7.25 HKD as of March 19 [4].

Group 1: Macro Insights - The recent FOMC meeting decided to pause interest rate cuts, aligning with market expectations, and highlighted a more optimistic view on inflation, suggesting that the recent energy supply shock is likely a one-time event [2] - There are concerns about potential stagflation, with the Fed raising its PCE inflation forecast and noting that the absolute level of new job creation is too low, posing risks [2] - Powell's comments on his future at the Fed depend on whether the new chairman, Waller, can be confirmed by the Senate in a timely manner, and whether the Trump administration will conclude its investigations [2] Group 2: Company Research - AIA Group (1299.HK) reported a 8.8% year-on-year decline in net profit attributable to shareholders for 2025, while new business value (NBV) increased by 17.1%. The company expects continued growth in NBV driven by agency and partner distribution channels [3] - Haitan International (1882.HK) achieved a 10.0% year-on-year revenue growth and a 7.2% increase in net profit attributable to shareholders for 2025. The company has adjusted its net profit forecasts for 2026-2027 downwards by 6.7% and 6.1% respectively, while introducing a new forecast for 2028 [4] - Geely Automobile (0175.HK) has adjusted its net profit forecasts for 2026 and 2027 down by 0.4% and 0.8% respectively, while introducing a new forecast for 2028. The company remains optimistic about product structure improvements and export growth [4] - Shengmei Shanghai (688082.SH) is progressing steadily in its cleaning equipment business, with new product development on track. The company is expected to see net profit attributable to shareholders of 1.829 billion, 2.285 billion, and 2.667 billion for 2026-2028 [5] - Saint Bella Group (2508.HK), a leader in high-end postpartum care, is well-positioned to benefit from industry upgrades and is expanding into overseas markets. The company forecasts adjusted net profits of 121 million, 178 million, and 279 million for 2025-2027 [6]

Investment Rating - The report gives a "Buy" rating for the company, Saint Bella Group [3][11]. Core Insights - Saint Bella Group is the leading high-end postpartum care and recovery group in Asia and China, leveraging a light asset model for rapid expansion and focusing on service standardization, specialization, customization, and digital upgrades [1][21]. - Despite a decline in the total number of newborns in China, the postpartum care industry has structural growth potential driven by the increasing willingness of affluent families to have children and the rising demand for professional postpartum care [1][11]. - The company is positioned to benefit from the dual trends of upgraded fertility consumption and accelerated industry consolidation, with head brands expected to gain market share through enhanced service experiences and operational efficiencies [1][11]. Summary by Sections Company Overview - Saint Bella Group operates a brand matrix covering various postpartum care services, including postpartum recovery and family care, with a focus on high-net-worth clients [21][25]. - The company has established 113 postpartum care centers globally, including in mainland China, Hong Kong, Singapore, and the United States, with plans for further international expansion [21][29]. Industry Analysis - The postpartum care industry in China is transitioning from quantity-driven growth to quality-driven growth, with a focus on high-income families who have a higher birth rate [2][11]. - The demand for postpartum care services is becoming increasingly essential, driven by changing perceptions and the need for quality care [2][11]. Competitive Advantages - The company utilizes a low-trust cost and efficient customer acquisition strategy through partnerships with high-end hotels and leveraging celebrity endorsements [2][3]. - A digital ecosystem centered around the Doctor Bella platform enhances customer experience and supports expansion efforts [2][3]. - The company has built a standardized operational system to ensure service quality and operational efficiency, facilitating scalable growth [2][3]. Financial Projections - The adjusted net profit for the company is projected to reach 1.21 billion, 1.78 billion, and 2.79 billion yuan for the years 2025 to 2027, with corresponding adjusted EPS of 0.19, 0.29, and 0.45 yuan [3][4]. - Revenue is expected to grow significantly, with a forecasted increase from 560 million yuan in 2023 to 1.62 billion yuan in 2027, reflecting a compound annual growth rate [4][11]. Investment Thesis - The company is well-positioned to capitalize on the structural upgrades in the postpartum care industry and the growing demand for high-quality services, particularly among affluent families [11][21]. - The expansion into overseas markets and the diversification of service offerings are expected to further enhance revenue potential and market presence [11][21].

Group 1: Federal Reserve Meeting Outcomes - The Federal Reserve maintained the federal funds rate target range at 3.50%-3.75%, in line with market expectations, with a probability of over 99% for no rate cut at this meeting[2][5] - One dissenting vote was recorded, with Stephen Miran advocating for a 25 basis point cut, contrasting with the majority's decision to keep rates unchanged[5] Group 2: Economic Outlook and Inflation - The Fed raised its 2026 PCE inflation forecast by 0.3 percentage points, reflecting concerns over potential supply shocks[3][10] - Powell expressed optimism regarding inflation, suggesting that recent energy supply shocks are likely to be temporary[3][7] Group 3: Employment and Economic Concerns - The Fed noted that the absolute level of new job creation is too low, indicating potential risks in the labor market[3][8] - The unemployment rate remains stable at 4.4%, with no significant changes observed in recent months[10] Group 4: Geopolitical Risks and Market Reactions - The geopolitical situation in the Middle East is influencing the Fed's decision-making, with potential delays in rate cuts depending on developments in the region[3][13] - Following the Fed's meeting, major U.S. stock indices fell, with the Dow Jones down 1.63%, S&P 500 down 1.36%, and Nasdaq down 1.46%[4]